Published on LinkedIn via Spencer Knight Jan Janisch-Hanzlik, 49, became the first person in the world to receive allogeneic CAR‑T...

Published by University of Tokyo via Nature Communications Researchers at the University of Tokyo have developed a novel system that...

Published on Drug Discovery News Recent FDA rejections of three advanced therapies, Capricor’s CAP‑1002, Ultragenyx’s DTX401, and Rocket...

Published on LinkedIn via Spencer Knight SERB Pharmaceuticals will acquire Y-mAbs Therapeutics for $412 million, marking a strategic...

Published on OncoDaily via Hung Trinh In a first‑in‑human trial led by UCLA, researchers demonstrated that hematopoietic stem cells...

Published by Cytotherapy via LinkedIn A new paper describes a fully integrated platform that automates three core CAR‑T manufacturing...

Published on LinkedIn via Spencer Knight In a groundbreaking study by Karolinska Institutet, ten patients born deaf due to a mutation in...

Published on LinkedIn via Spencer Knight The FDA has granted two approvals within 24 hours. Novartis’s Leqvio (inclisiran), a...

Published in Alliance for Regenerative Medicine (April 2025 Preview) A new whitepaper from the Alliance for Regenerative Medicine...

Published on Mass General Brigham After years of debilitating pain from sickle cell disease, Allan Byamukama became one of the first...

Published on LinkedIn via Spencer Knight AbbVie has secured worldwide rights to ISB 2001, a first-in-class trispecific antibody developed...

Published on LinkedIn via Spencer Knight GSK has entered a $12 billion licensing deal with China’s Hengrui Pharma, paying $500 million...

Published on Autolus Therapeutics News Releases Autolus’s CAR‑T therapy, AUCATZYL (obecabtagene autoleucel), has received marketing...

Published by Regenerative Medicine Foundation The July 2025 Healthspan Compass newsletter showcases several advances in longevity and...

Dear Members, I hope this message finds you well. On behalf of the Sarawak Society for Cell and Gene Therapy Research (SSCTR), I am...

Published on Technology Networks A new study identifies TAF1 as a molecular switch that helps adult hematopoietic stem cells transition...

Published on Stanford Medicine News Stanford researchers have successfully used an antibody, briquilimab, to prepare children with...

Published in Cytotherapy Volume 27, Issue 4 A recent review in Cytotherapy highlights the ability of mesenchymal stromal cell (MSC)...

On 9 July 2025, I had the privilege of attending the Value-Based Healthcare (VBHC) Conference 2025, organized by the Pharmaceutical...

A new paper in Cytotherapy describes an integrated platform that may significantly accelerate how CAR-T cells are produced. Researchers...